Midgard
GlycoNex, Inc.

GlycoNex, Inc.

New Taipei City, Taiwan glyconex.com.tw From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

GlycoNex, Inc. is a clinical-stage biopharmaceutical company in New Taipei City, Taiwan. It develops antibody-based therapeutics focused on glycan-directed cancer immunotherapy, and also provides antibody CDMO services and biosimilar development.

GlycoNex, Inc. is a CRDMO in New Taipei City, Taiwan, founded in 2001. It lists 10 services, including Cell line development, Process development and scale-up and GMP-compliant antibody manufacturing. It names GMP on its listing.

Services

  • Cell line development

    Establishes stable cell lines and selects clones for antibody and antibody-based modalities.

    Cell line development

  • Process development and scale-up

    Develops and optimizes upstream and downstream processes and scales them up for manufacturing.

  • GMP-compliant antibody manufacturing

    Produces antibodies at 50 L and 200 L scale for Phase 1 clinical supply.

    CDMO: development & manufacturing

  • Technology transfer

    Provides structured transfer and project management from development to manufacturing.

  • Analytical development

    Supports development, characterization, and quality control of monoclonal antibodies and antibody-drug conjugates.

  • Glycan isolation and purification

    Isolates and purifies glycans from biological materials for characterization, screening, and research.

  • Glycan semi-synthesis

    Prepares and structurally modifies glycans from naturally derived carbohydrate materials.

  • Glycan structure analysis

    Characterizes glycan composition, branching patterns, linkages, and other structural features.

2 more services
  • Glycosylation-site analysis
  • Monosaccharide analysis

How to order from GlycoNex, Inc.

They take quote requests by email. You can contact them directly from this page, or request a quote through Midgard.

Capabilities

Assays and studies
  • Antibodies
  • ADCs
  • Process development
  • HPLC
  • Bispecifics
  • Analytical development
15 more
  • SPR
  • ELISA
  • Cell-based assays
  • SEC-HPLC
  • CIEX / AEX-HPLC
  • SDS-PAGE
  • CE-SDS
  • RP-HPLC
  • cIEF
  • Protein A-HPLC
  • A280
  • ADCC / CDC
  • Intact-protein MS
  • Peptide mapping
  • PTM profiling
Scale and capacity
  • 50 L pilot-scale
  • 200 L GMP-compliant manufacturing
  • 50 L + 200 L GMP antibody facility
Therapeutic areas
  • Oncology
  • GI cancers
  • Solid tumors
  • Osteoporosis
  • Autoimmune disease

Instruments and platforms

  • SEC-HPLC
  • CIEX / AEX-HPLC
  • SDS-PAGE
  • CE-SDS
  • RP-HPLC
  • cIEF
7 more
  • Protein A-HPLC
  • A280
  • ELISA
  • SPR
  • Intact-protein MS
  • CD
  • DSC

Modalities and species

Modalities
  • Antibody
  • Bispecific
  • ADC
  • Biosimilar
Species and models
  • GI cancers
  • Solid tumors
  • Osteoporosis
  • Autoimmune disease

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: antibody manufacturing

  • GLPSelf-reported

Details

Type
CRDMO
Founded
2001
Based in
New Taipei City, Taiwan
Sites
Taipei, Taiwan
Serves
Taiwan, Japan

Similar labs